Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Larimar Therapeutics, Inc. | 55,150 | reported | 19 May 2026 | tx 8+137,400 |
| BIOSPECIFICS TECHNOLOGIES CORP | 0 | reported | 02 Dec 2020 | tx 3+230,000−100,000 |
| ACHILLION PHARMACEUTICALS INC | 0 | reported | 28 Jan 2020 | tx 42+3,618,234−3,363,234 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Larimar Therapeutics, Inc. | 55,150 | 0.00 USD | deriv |
| 13 May 2025 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 17 May 2023 | PURCHASE | Larimar Therapeutics, Inc. | 2,750 | 3.73 USD | first after silence |
| 09 May 2023 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 10 May 2022 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 12 May 2021 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 02 Dec 2020 | OTHER | BIOSPECIFICS TECHNOLOGIES CORP | 100,000 | 24.78 USD | deriv |
| 29 Sept 2020 | GRANT_AWARD | Larimar Therapeutics, Inc. | 16,600 | 0.00 USD | deriv |
| 28 May 2020 | GRANT_AWARD | BIOSPECIFICS TECHNOLOGIES CORP | 130,000 | 0.00 USD | deriv |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 3,500 | 6.30 USD | |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 87,766 | — | deriv |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 30,000 | — | deriv |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 1,097,000 | — | deriv |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 419,000 | — | deriv |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 200,000 | — | deriv |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 142,000 | — | deriv |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 100,000 | — | deriv |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 185,000 | — | deriv |
| 28 Jan 2020 | OTHER | ACHILLION PHARMACEUTICALS INC | 632,000 | — | deriv |
| 16 Oct 2019 | SALE | ACHILLION PHARMACEUTICALS INC | 33,250 | 6.37 USD | |
| 16 Oct 2019 | EXERCISE | ACHILLION PHARMACEUTICALS INC | 100,234 | 3.10 USD | |
| 16 Oct 2019 | EXERCISE | ACHILLION PHARMACEUTICALS INC | 33,250 | 3.28 USD | |
| 16 Oct 2019 | SALE | ACHILLION PHARMACEUTICALS INC | 100,234 | 6.37 USD | |
| 16 Oct 2019 | EXERCISE | ACHILLION PHARMACEUTICALS INC | 33,250 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 17 May 2023.